The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy

Journal of Nippon Medical School

Volumn 74, Issue 3, 2007, Pages 236-240

  Kushimoto, Shigeki ^a   Shibata, Yasushi ^a   Koido, Yuichi ^a   Kawai, Makoto ^a   Yokota, Hiroyuki ^a   Yamamoto, Yasuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Corticosteroid; Critical ill; Procalcitonin; Sepsis

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HORMONE DETERMINATION; HUMAN; MALE; PATIENT ASSESSMENT;

ADRENAL CORTEX HORMONES; AGED; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX;

EID: 34347336295     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.236     Document Type: Article

References (33)

1. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al.: Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 1742-1751.
2. Alberti C, Brun-Buisson C, Goodman SV, et al.: European Sepsis Group: Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003; 168: 77-84.
3. Vesentini S, Bassi C, Talamini G, et al.: Prospective comparison of C-reactive protein level. Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993; 80: 755-757.
4. Rushforth JA, Hoy CM, Kite P, et al.: Rapid diagnosis of central venous catheter sepsis. Lancet 1993; 342: 402-403.
5. Weglohner W, Struck J, Fischer-Schulz C, et al.: Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides 2001; 22: 2099-2103.
6. Bribaum RS, Mahoney WC, Burns DM, et al.: Identification of procalcitonin in a rat medullary thyroid carcinoma cell line. J Biol Chem 1984; 259: 2870-2807.
7. Jacobs JW, Lund PK, Potts JT Jr, et al.: Procalcitonin is a glycoprotein. J Biol Chem 1981; 256: 2803-2807.
8. Oberhoffer M, stonans I, Russwurm S, et al.: Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134: 49-55.
9. Müller B, White JC, Nylen ES, et al.: Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metabol 2001; 86: 396-404.
10. Linscheid P, Seboek D, Schaer DJ, et al.: Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004; 32: 1715-1721.
11. Reinhart K, Karzai W, Meisner M: Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26: 1193-1200.
12. Ugarte H, Silva E, Mercan D, et al.: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504.
13. Clec'h C, Ferriere F, Karoubi P, et al.: Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166-1169.
14. Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisones on mortality in patients with septic shock. JAMA 2002; 288: 862-871.
15. Mrik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31: 141-145.
16. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348: 727-734.
17. Minneci PC, Deans KJ, Bsnkd DM, et al.: Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004; 141: 47-56.
18. Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids - New mechanisms for old drugs. N Engl J Med 2005; 353: 1711-1723.
19. Rinaldi S, Adembri C, Grechi S, et al.: Low-dose hydrocortisone during severe sepsis: effects on microalbuminemia. Crit Care Med 2006; 34: 2334-2339.
20. th ed (Brunton LL, Lazo JS, Parker KL, eds), 2005; pp 1587-1612, McGraw-Hill, New York.
21. Medui GU, Headley AS, Golden E, et al.: Effect of prolonged methylpredonisolone therapy in unresolving acute respiratory distress syndrome: a randomized controle trial. JAMA 1998; 280: 159-165.
22. Members of the American College of Chest Physicians/Society of Crit Care Med Consensus Conference Committee: American College of Chest Physicians/Society of Crit Care Med Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
23. Uzzan B, Cohen R, Nicolas P, et al.: Procalcitonin as a diagnostic test for sepsis in critically ill adylts and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.
24. Jensen JU, Heslet L, Jensen TH, et al.: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34: 2596-2602.
25. rd revision and expanded edition, 2000 Thieme, Stuttgart.
26. Assicot M, Gendrel D, Carsin H, et al.: High serum procalcitonin concentration in patients with sepsis and infection. Lancet 1993; 341: 515-518.
27. Luzzani A, Polati E, Dorizzi R, et al.: Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737-1741.
28. Meisner M, Tschaikowsky K, Palmaers T, et al.: Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3: 45-50.
29. Müller B, Becker KL, Schächinger H, et al.: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977-983.
30. Harbarth S, Holeckova K, Froidevaux C, et al.: Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
31. th edition (Brunton LL, Lazo JS, Parker KL, eds), 2006; pp 1587-1612, McGraw-Hill, New York.
32. Kushimoto S, Shibata Y, Koido Y, et al.: The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in patients requiring corticosteroid therapy. J Nippon Med Sch 2006; (in press).
33. Kushimoto S, Koido Y, Kawai M, et al.: The clinical value of procalcitonin in assessment of severity of bacterial infection in patients requiring corticosteroid therapy. J Jpn Biomed Forum 2006; 16: 115-121.